C12N 2501/125
Stem cell factor [scf], c-kit ligand [kl]
Official title: Stem cell factor [SCF], c-kit ligand [KL]
C12N2501/125 (Stem cell factor [scf], c-kit ligand [kl]) appears on 474 US grants and 985 published applications in this corpus.
Search patents in C12N- Granted patents
- 474
- Published applications
- 985
- Assignees
- 523
- Inventors
- 1,808
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 6 | 0 |
| 1996 | 4 | 0 |
| 1997 | 17 | 0 |
| 1998 | 13 | 0 |
| 1999 | 11 | 0 |
| 2000 | 14 | 0 |
| 2001 | 11 | 8 |
| 2002 | 12 | 23 |
| 2003 | 13 | 18 |
| 2004 | 5 | 34 |
| 2005 | 11 | 45 |
| 2006 | 10 | 25 |
| 2007 | 7 | 28 |
| 2008 | 14 | 22 |
| 2009 | 12 | 28 |
| 2010 | 12 | 34 |
| 2011 | 10 | 26 |
| 2012 | 18 | 26 |
| 2013 | 14 | 31 |
| 2014 | 15 | 29 |
| 2015 | 30 | 36 |
| 2016 | 24 | 42 |
| 2017 | 19 | 29 |
| 2018 | 16 | 48 |
| 2019 | 13 | 40 |
| 2020 | 22 | 56 |
| 2021 | 16 | 49 |
| 2022 | 13 | 61 |
| 2023 | 20 | 56 |
| 2024 | 23 | 70 |
| 2025 | 28 | 65 |
| 2026 | 20 | 56 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of culturing quiescent hematopoietic stem cells and treatment methods6 Oct 2026US 12,753,389 B2Icahn School of Medicine at Mount Sinai
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Compositions and methods for providing hematopoietic function without HLA matching22 Sep 2026US 12,741,001 B2Fred Hutchinson Cancer Center
- Media and methods for differentiating natural killer cells1 Sep 2026US 12,723,233 B2Stemcell Technologies Canada Inc.
- Methods for directed differentiation of pluripotent stem cells to HLA homozygous immune cells25 Aug 2026US 12,716,058 B2FUJIFILM Cellular Dynamics, Inc.
- T cell progenitor production method1 Oct 2026US 2026/0297522 A1Kyoto University
- Method for modulating the differentiation and functions of human dendritic cells1 Oct 2026US 2026/0297524 A1Centre National De La Recherche Scientifique
- Genetically engineered human fetal liver niche as platform for biomanufacturing of hematopoietic stem cells1 Oct 2026US 2026/0297528 A1Arizona Board of Regents on behalf of Arizona State University
- SIRPalpha Knockout iPSC-derived and CAR-comprising Macrophages with Enhanced Anti-tumor Activity24 Sep 2026US 2026/0284104 A1Wisconsin Alumni Research Foundation
- Media and methods for differentiating t cells from hematopoietic stem cells17 Sep 2026US 2026/0272984 A1The Regents of the University of California
Most cited
By later US patents
- Method for improving autologous transplantation264US 5,199,942 AImmunex Corporation · 1993
- Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells210US 5,437,994 AThe Regents of the University of Michigan · 1995
- Methods and device for culturing human hematopoietic cells and their precursors206US 5,635,387 ACellPro, Inc. · 1997
- Pluripotential embryonic stem cells and methods of making same205US 5,453,357 AVanderbilt University · 1995
- Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells159US 6,326,198 B1The Regents of the University of Michigan · 2001